In this issue, volume 5, #4, there are 14 manuscripts. We expect to publish volume 5, issue #5 and issue #6, in October and December, respectively. If the current trend continues, we should exceed 80 manuscripts in volume 5, compared to 40 a couple of years ago. This doubling, in 2 years’ time, is reflected in our ‘unique individual readership’, which increases by over 2,000 every month, with the total now approaching 50,000.With the doubling of our reviews, the need for peer reviewers is greater than ever; so, I would invite our readership to participate in the peer review. On the home page of the JCHIMP website archives, there is a perspective piece on how to do peer review in volume 2, issue #3. There is special attention to reviewing case reports which represent about 50% of our review requirements.There are three review articles and one research paper in this issue: a promising new pharmacologic approach to preventing delirium in the ICU in geriatric patients (1); apixalban for reducing risk of DVT in knee and hip replacement surgery (2); the management of pyogenic cholangitis with ERCP (3) and organizing and prioritizing symptoms of patients presenting with Ebola viral disease (4).Our nine case reports include multiorgan failure from synthetic cannabinoids (5); pathological chondroid differentiation in metastatic breast cancer (6), hyperglycemic unmasking of hemichorea (7), emphysematous gastritis (8), thrombus entrapment syndrome in a patent foramen ovale (9), sarcoidosis complicated by fatal chylothorax (10), statin induced acute necrotizing myopathy (11), and two imaging cases – a heating pad induced problem (12) and ‘goose skin’ in a pellagra patient (13). There is also a letter to the editor and a response to this letter regarding a comment in issue #3 regarding the efficacy of a new emergent treatment for life-threatening hyperkalemia (14, 15).The sources of the published manuscripts are Reading (PA), Good Samaritan (MD), Maryland Mid-town, St. Mary's (CA), Washington DC Hospital Center, Einstein (PA), Union Memorial (MD), University Autonomous Potosi (MEX), McKeesport (PA), University of Illinois Peoria, Interfaith (NY), and Pharm Inc. (TX).